Open AccessP1351: CHARACTERIZING ALLOGENEIC STEM CELL TRANSPLANTATION SAFETY IN PATIENTS WITH HEMATOLOGIC MALIGNANCIES AFTER PEMBROLIZUMAB THERAPY
Author(s) -
Kuruvilla J.,
Armand P.,
Herrera A. F.,
Ribrag V.,
Brice P.,
Thieblemont C.,
Von Tresckow B.,
Kim E.,
Marinello P.,
Chakraborty S.,
Orlowski R.,
Zinzani P. L.
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000848268.24972.7c
Subject(s) - medicine , pembrolizumab , cumulative incidence , transplantation , incidence (geometry) , oncology , lymphoma , gastroenterology , cancer , immunotherapy , physics , optics